Diabetes epidemiology and management最新文献

{"title":"Association between therapeutic inertia and future hypoglycemia among patients with type 2 diabetes","authors":"Helen NC Chen ,&nbsp;Lap Pui Chung ,&nbsp;Yutong Chen ,&nbsp;Titus Schleyer ,&nbsp;Kai DeMeritt ,&nbsp;Ethan A. Halm ,&nbsp;Lisa S. Chow ,&nbsp;Lan Luo ,&nbsp;Julian Wolfson","doi":"10.1016/j.deman.2026.100305","DOIUrl":"10.1016/j.deman.2026.100305","url":null,"abstract":"<div><h3>Introduction</h3><div>Therapeutic inertia (TI), the failure to adjust therapy when HbA1c remains above- target, is a barrier to optimal glycemic control in type 2 diabetes (T2D). This study examined the association between TI and subsequent-year hypoglycemia visit, and whether continuous glucose monitoring (CGM) modifies this relationship.</div></div><div><h3>Methods</h3><div>We analyzed electronic health records (2017–2023) from two Midwest US healthcare systems, including adults with T2D, at least one above-target HbA1c (&gt;7% for ages 18–64; &gt;8% for ages ≥65), and glucose-lowering prescriptions. TI was calculated annually as the percentage of above-target HbA1c results without prescription changes within 30 days. We fitted logistic regression models to examine whether high TI (&gt;50%) was associated with subsequent-year hypoglycemia visits. An interaction term tested whether this association differed between those who used vs. did not use CGM.</div></div><div><h3>Results</h3><div>Among 65,983 participants (mean age 56, 51% male, 75% White), mean HbA1c at last follow-up was 8.1% (ages 18–64) and 8.0% (ages ≥ 65). High TI was associated with 74% increased odds of hypoglycemia visit (OR = 1.74; 95% CI: 1.61–1.88; <em>p</em> &lt; 0.001). Insulin users had threefold higher odds (OR = 2.95; <em>p</em> &lt; 0.001). Medicare beneficiaries had 47% higher odds than Medicaid beneficiaries. Adults aged 18–44 years had more hypoglycemia visits compared to other age groups. Low CGM use (7%) limited the interpretation of interaction effects (95% CI: 0.47–1.1, <em>p</em> = 0.12).</div></div><div><h3>Conclusions</h3><div>In this cohort, high TI predicted hypoglycemia-visit. Further research is needed to understand TI drivers and how to balance improving glycemic control without increasing the risk of hypoglycemia.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100305"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147394982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends in age-adjusted mortality among older U.S. adults with co-morbid diabetes and hypertensive diseases: A multiple cause of death analysis, 1999–2023","authors":"Meer Murtaza ,&nbsp;Hafsa Shahid ,&nbsp;Muhammad Bilal Khanzada ,&nbsp;Inshrah Nawaz ,&nbsp;Ayeza Nawaz ,&nbsp;Iffat Ambreen Magsi ,&nbsp;Fentahun Bikale Kebede ,&nbsp;Aniqua Aftab ,&nbsp;Muhammad Seerat Ali ,&nbsp;Hassan Qadir ,&nbsp;Mehtab Ali","doi":"10.1016/j.deman.2026.100304","DOIUrl":"10.1016/j.deman.2026.100304","url":null,"abstract":"<div><h3>Introduction</h3><div>Diabetes mellitus (DM) increases the risk of Hypertension (HTN) through mechanisms such as vascular dysfunction, increased arterial stiffness, and diabetic kidney disease. Both DM and HTN often occur together due to shared risk factors and are common in the United States. We analyzed trends in DM and HTN-related mortality in the U.S. from 1999 to 2023, focusing on sex, racial, and regional differences, as well as specific age groups.</div></div><div><h3>Methods</h3><div>The CDC WONDER database was used to extract mortality data among adults (≥ 65 years old) in the US with concomitant DM and HTN from 1999 to 2023, expressed per 100,000 persons. Age-Adjusted Mortality Rates (AAMRs) were stratified by year, gender, race, age groups, and geographic distribution. The change in AAMRs was calculated as Annual Percentage Change (APC) with 95% Confidence Intervals (CIs).</div></div><div><h3>Results</h3><div>A total of 2132,393 deaths related to the co-morbidity of DM and HTN were recorded between 1999 and 2023. The AAMRs increased from 59.89 to 264.18 deaths per 100,000 population during this period, representing a 4.4-fold increase relative to the 1999 rate. A peak in mortality occurred during 2018-2021, with the AAMR reaching 302.62 in 2021 and an APC of 15.33 (95 % CI: 9.13 to 21.87; p = 0.00007). Men consistently had higher AAMRs than women (325.39 vs. 216.94 in 2023). Among racial and ethnic groups, NH Black or African American individuals had the highest average AAMR, followed by NH American Indian or Alaska Native, Hispanic or Latino, NH Asian or Pacific Islander, and NH White populations. Mortality rates increased with age, with those aged 85+ showing the highest averages, followed by the 75–84 and 65–74 age groups. From 1999 to 2023, the South had the highest average AAMR, followed by the West, Midwest, and Northeast. Rural areas exhibited significantly higher average AAMR (198.27 vs. 178.7) than urban areas from 1999 to 2020. The location of death varied: 37.56 % occurred in medical facilities, 30.45 % at the decedent’s home, 3.41 % in hospices, 24.62 % in nursing homes, and 3.96 % in other or unknown places. The highest AAMRs were observed in Mississippi (324.78), the District of Columbia (323.76), and Oklahoma (302.29), while the lowest were in Massachusetts (98.54), Connecticut (112.04), and Utah (113.23).</div></div><div><h3>Conclusion</h3><div>DM and HTN-related mortality have risen significantly over time in the United States, with a peak between 2018 and 2021. Our study shows a 4.4-fold increase in DM and HTN-related deaths in the U.S. from 1999 to 2023. The highest rates were observed in men aged 85+ from rural areas of the NH Black community in the Southern region. This underscores the need for enhanced public health surveillance, better healthcare, and targeted interventions for these groups to reduce disparities.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100304"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147394931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of chronic kidney disease and associated risk factors in patients with Type 2 Diabetes Mellitus in Basrah, Iraq: A cross-sectional study","authors":"Haider Ayad Alidrisi,&nbsp;Khulood Abed Reman,&nbsp;Emad Sakran Alhubaish,&nbsp;Ibrahim Hani Hussein,&nbsp;Hussein Ali Nwayyir,&nbsp;Ibrahim Abbood Zaboon,&nbsp;Musaab Ali Ashkar,&nbsp;Ali Hussain Alhamza,&nbsp;Abbas Ali Mansour","doi":"10.1016/j.deman.2026.100301","DOIUrl":"10.1016/j.deman.2026.100301","url":null,"abstract":"<div><h3>Aims</h3><div>Chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM) is underdiagnosed. We aimed to evaluate the prevalence of undiagnosed CKD in patients with T2DM and identify factors associated with increased prevalence of CKD.</div></div><div><h3>Methods</h3><div>This cross-sectional study included patients with T2DM presenting for their visit to two centers in Basrah, Southern Iraq. CKD was diagnosed based on the measurement of estimated glomerular filtration rate (eGFR) and urine albumin creatinine ratio (UACR). The association of the patients’ demographic and biochemical characteristics with CKD was analyzed using logistic regression analysis.</div></div><div><h3>Results</h3><div>Among 1779 patients (mean age 55.0 ± 11.5 years, 39.0% male, mean T2DM duration 8.9 ± 6.9years), CKD was diagnosed in 887 (49.9%) patients. Specifically, 13.4% had eGFR &lt;60 mL/min/1.73 m²and 45.4% had UACR ≥30 mg/g. Independent predictors of CKD included increasing age (OR 1.03,95% CI 1.02–1.04), longer T2DM duration (OR 1.03, 95% CI 1.01–1.04), elevated HbA1c (OR 1.1, 95% CI1.09–1.19), higher total cholesterol (OR 1.008, 95% CI 1.003–1.01), uncontrolled hypertension (OR 1.4,95% CI 1.03–2.10), and lower HDL cholesterol (OR 0.9, 95% CI 0.9–0.99).</div></div><div><h3>Conclusions</h3><div>CKD was highly prevalent, affecting almost half of the patients with T2DM. Our findings highlighted the multiple risk factors associated with CKD and emphasized the importance of active CKD screening and comprehensive management strategies.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100301"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis","authors":"Ricardo E T Navarrete ,&nbsp;Joao Fernandes ,&nbsp;Isabel Fonseca ,&nbsp;José Luis Silvano ,&nbsp;La Salete Martins ,&nbsp;Joao Roberto Sa","doi":"10.1016/j.deman.2026.100302","DOIUrl":"10.1016/j.deman.2026.100302","url":null,"abstract":"<div><h3>Background</h3><div>Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are key cardiorenal agents, yet their safety and efficacy in kidney transplant recipients (KTRs) with post-transplant diabetes mellitus (PTDM) remain insufficiently characterized.</div></div><div><h3>Objective</h3><div>To evaluate the renal safety, tolerability, and cardiometabolic profile associated with SGLT2 inhibitor use in this population.</div></div><div><h3>Methods</h3><div>This single-center retrospective cohort screened 183 KTRs prescribed GLP-1 receptor agonists and/or SGLT2i (August 2013–April 2024). After applying prespecified exclusion criteria, 65 kidney transplant recipients with PTDM receiving SGLT2i for &gt;3 months were included (mean treatment duration 2.56 ± 1.37 years). Primary outcomes were renal safety (annualized eGFR slope and uPCR/uACR). Secondary outcomes included cardiometabolic/hemodynamic measures and adverse events.</div></div><div><h3>Results</h3><div>Allograft function was stable, with an annualized eGFR slope of +1.35 mL/min/1.73 m²/year (95% CI: –0.49 to +3.19; p = 0.148). Proteinuria markers (uPCR, uACR) showed no significant increase. Serum urea rose (70.00 ± 25.80 to 75.30 ± 33.86 mg/dL, p = 0.003), while serum creatinine and cystatin C were unchanged. Body weight decreased by 3.02 kg (p = 0.001) and BMI by 1.24 kg/m² (p &lt; 0.001). Systolic and diastolic blood pressure were lower by 7.0 and 4.9 mmHg, respectively (both p &lt; 0.001). Reductions were observed in total cholesterol (172.60 ± 33.60 to 158.90 ± 37.70 mg/dL, p = 0.001) and LDL-cholesterol (87.60 ± 36.20 to 75.80 ± 33.60 mg/dL, p = 0.001). Serum uric acid decreased from 6.56 ± 1.56 to 6.24 ± 1.65 mg/dL (p = 0.021). Electrolytes were stable. Urinary tract infections occurred in 15.4% (predominantly asymptomatic). No cases of euglycemic diabetic ketoacidosis, allograft rejection, or genital infections were observed.</div></div><div><h3>Conclusions</h3><div>In KTRs with PTDM, intermediate-term SGLT2i therapy was associated with preserved allograft function, cardiometabolic benefits, and a favorable safety profile. These real-world data describe a clinical profile supporting further investigation and provide rationale for prospective trials.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100302"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147612129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long work hours, suboptimal diabetes management, and differences by sex and race/ethnicity, NHANES (2011-2018)","authors":"Tailisha Gonzalez ,&nbsp;Margrethe Horlyck-Romanovsky ,&nbsp;Terry T-K Huang ,&nbsp;Sandra E. Echeverria","doi":"10.1016/j.deman.2026.100316","DOIUrl":"10.1016/j.deman.2026.100316","url":null,"abstract":"<div><div>In the United States (US), occupational segregation by sex and race/ethnicity can contribute to health disparities. Although work schedule characteristics have been previously linked to elevated cardiovascular risk, little is known about the effects on chronic disease management in women and minoritized workers. We examined the association between work hours and diabetes management among US workers, testing for differences by sex and race/ethnicity. We utilized 2011–2018 National Health and Nutrition Examination Survey (NHANES) data on working adults (age ≥20 years) with diagnosed diabetes (<em>n</em> = 1041). Suboptimal diabetes management was defined as HbA1c ≥7%. Work hours were categorized per WHO guidelines (&lt;35hrs/week, 35–40, 41–54, ≥55). We conducted additional analyses with the US-standard (&lt;35hrs/week, 35–40,&gt;40). Log binomial regression models generated crude and adjusted prevalence ratios (aPR). We tested for interaction by sex and race/ethnicity. Significance levels were set at <em>p</em> &lt; 0.05. More than half (54.6%) of US workers with diabetes had HbA1c ≥7% (<em>p</em> &lt; 0.001). Pooled analyses showed no significant associations between work hours and diabetes management. In stratified models with WHO categorized work hours, working ≥55 h/week increased the prevalence of suboptimal diabetes management among women (aPR:1.85; 95%CI: 1.28–2.67), Latino (aPR: 1.37; 95%CI: 1.03–1.82), and White (aPR: 1.50; 95%CI: 1.04–2.15) workers compared to similar groups working 35–40 h/week. The analysis with US-standard hours masked differences for racial/ethnic groups, but not women and men. In both analyses, &lt;35 h/week was protective for men only. This study highlights the urgent need to examine how and for whom work conditions contribute to health inequities.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100316"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147802511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diabetes screening practices of japanese dental hygienists: The role of attitudes and training","authors":"Rie Kudoh,&nbsp;Taiga Shibayama","doi":"10.1016/j.deman.2025.100296","DOIUrl":"10.1016/j.deman.2025.100296","url":null,"abstract":"<div><h3>Background</h3><div>Despite the bidirectional relationship between diabetes and periodontal disease, dental hygienists' (DHs') engagement in diabetes screening remains underexplored in Japan. This study examined associations between attitudes and diabetes screening practices among Japanese DHs.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted among 234 DHs in the Kanto region between December 2023 and February 2024. After excluding invalid responses, 75 (response rate: 32.1 %) were analyzed. Attitudes and practices were assessed using a self-administered questionnaire. Exploratory factor analysis identified underlying constructs, and multiple regression analyses examined associations between attitudes and screening practices.</div></div><div><h3>Results</h3><div>Only 36 % had received diabetes management training. Factor analysis identified two attitude factors—willingness to manage diabetes and lack of knowledge and confidence—and two practice factors—checking diabetes management status and checking diabetes therapeutic management status. Willingness to manage diabetes was positively associated with all screening practices: checking diabetes management status (β = 0.34, 95 % CI 0.28–1.41), checking diabetes therapeutic management status (β = 0.39, 95 % CI 0.22–0.84), and symptom checking (β = 0.30, 95 % CI 0.12–0.72), indicating substantial effects. Lack of knowledge and confidence was negatively associated with checking diabetes management status (β = -0.33, 95 % CI -0.94 to -0.17), reflecting a moderate effect. Clinical experience and diabetes education experience also predicted symptom checking, highlighting the importance of structured training.</div></div><div><h3>Conclusions</h3><div>Educational interventions targeting knowledge, confidence, and willingness are essential to promote diabetes screening practices among DHs. These findings provide evidence for developing targeted training programs to enhance medical-dental collaboration in diabetes care.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100296"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Poor glycemic control and kidney function decline in older adults: Evidence from the health and retirement study","authors":"Fan Zhang,&nbsp;Yifei Zhong","doi":"10.1016/j.deman.2026.100313","DOIUrl":"10.1016/j.deman.2026.100313","url":null,"abstract":"<div><div>Chronic kidney disease is common in older adults, and diabetes is a major contributor to kidney function decline. However, the relationship between glycemic control and long-term kidney function trajectories in older populations remains incompletely understood. We examined the association between diabetes, glycemic control, and longitudinal changes in kidney function using data from 9,281 participants in the Health and Retirement Study. Estimated glomerular filtration rate based on cystatin C (eGFR_cys) was analyzed using linear mixed-effects models. Participants were categorized as having no diabetes, diabetes with good glycemic control (HbA1c &lt;7%), or diabetes with poor glycemic control (HbA1c ≥7%). Over 8 years, eGFR_cys declined by -6.50 mL/min/1.73 m² per 4-year interval among participants without diabetes. Individuals with diabetes experienced a faster decline compared with those without diabetes. When stratified by glycemic control, the rate of eGFR_cys decline did not differ significantly between participants with good glycemic control and those without diabetes, whereas those with poor glycemic control showed a substantially steeper decline (additional -3.98 mL/min/1.73 m² per 4-year interval). These findings suggest that poor glycemic control is associated with accelerated kidney function decline in older adults, whereas well-controlled diabetes shows trajectories similar to those without diabetes.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100313"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147709407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Decision-support for functional insulin therapy on multiple daily injections: An integrated qualitative study of patients and healthcare professionals","authors":"Arnaud Bubeck ,&nbsp;Coline Hehn ,&nbsp;Marie Barroyer ,&nbsp;Nicolas Naïditch","doi":"10.1016/j.deman.2026.100306","DOIUrl":"10.1016/j.deman.2026.100306","url":null,"abstract":"<div><h3>Background</h3><div>Diabetes technology innovation increasingly focuses on pumps and hybrid closed-loop systems, yet many people living with type 1 diabetes remain on basal–bolus multiple daily injections. Digital decision-support tools may extend algorithmic assistance to pen regimens, but evidence on their adoption and role in routine care remains limited.</div></div><div><h3>Methods</h3><div>Integrated qualitative analysis of 25 semi-structured interviews collected in France (patients <em>n</em> = 15; healthcare professionals <em>n</em> = 10). Data were analysed using reflexive thematic analysis with cross-dataset comparison.</div></div><div><h3>Results</h3><div>Participants situated EkiYou, a mobile decision-support application for pen-treated regimens, within a hierarchised \"innovation landscape\" where pumps are seen as the most legitimate option. The application was valued—primarily by people with type 1 diabetes—for extending algorithmic support to pen users and reducing feelings of being \"left behind\". Its clearest contribution concerned functional insulin therapy: meal-entry and food-search routines, insulin-on-board, and personalised parameters scaffolded dose decisions, reducing dose-related uncertainty and meal-time anxiety for some, while adding time and attentional demands that most participants described as acceptable. Clinicians also used EkiYou as a bridge during pump–pen alternation and as a step toward calibrated trust in algorithmic recommendations. However, discontinuation occurred when the tool conflicted with embodied self-management routines, and food-database frictions were socially patterned. Time constraints in routine care and the need for nursing delegation appear as critical implementation determinants.</div></div><div><h3>Conclusions</h3><div>EkiYou may act as a socio-technical scaffold for functional insulin therapy on pens and as a transition-support tool in an increasingly automated care environment. Scaling will require organisational support and attention to unequal capacities for sustained use.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100306"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147612130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diet quality as assessed by the healthy eating Index-2020 among individuals diagnosed with and without type 2 diabetes","authors":"Minghao Zhou ,&nbsp;Hairui Yu ,&nbsp;Renee Underwood ,&nbsp;Hongning Cai ,&nbsp;Tung-Sung Tseng ,&nbsp;Susu Luo","doi":"10.1016/j.deman.2025.100299","DOIUrl":"10.1016/j.deman.2025.100299","url":null,"abstract":"<div><h3>Background</h3><div>Dietary management is key to preventing and controlling type 2 diabetes mellitus (T2DM). However, few studies have examined differences in Healthy Eating Index (HEI-2020) scores and components among individuals with and without diagnosed T2DM. This study aimed to assess gender differences in HEI-2020 scores and its 13 components by T2DM status.</div></div><div><h3>Methods</h3><div>Using National Health and Nutrition Examination Survey (NHANES) data from 2011 to 2018, this cross-sectional study analyzed 19,464 adults. Diagnosed T2DM was identified via self-report or diabetes medication use. Diet quality was assessed using the HEI-2020, scored from 0 to 100, with a higher HEI score indicates better dietary quality. HEI-2020 scores were calculated per person using a standard scoring algorithm. Survey-weighted descriptive analyses and regression models were applied.</div></div><div><h3>Results</h3><div>The prevalence of diagnosed T2DM in the US adults (≥20 years) was 9.9%, with an average HEI-2020 score of 53.9. In unadjusted analyses, males with diagnosed T2DM had a significantly higher HEI score than those without (53.3 vs. 51.8, respectively) . Across both sexes, individuals with diagnosed T2DM reported higher HEI component scores for added sugar, indicating lower sugar intake, but lower scores for sodium and refined grains, indicating higher intake of these components, compared to those without diagnoses. Age- and sex-specific patterns were evident in adjusted models: adults aged ≥60 years with T2DM consumed less added sugar but more sodium than their non-diagnosed counterparts, while younger women (20–40 years) with T2DM reported higher added sugar intake.</div></div><div><h3>Conclusions</h3><div>Diet quality among adults with diagnosed T2DM was heterogeneous rather than uniformly improved. Although lower added sugar intake represents a favorable dietary change, persistently high sodium and refined grain consumption remains a concern, particularly among older adults, and poorer sugar intake was observed among younger women. These findings highlight important gaps in dietary management following diabetes diagnosis and underscore the need for targeted, subgroup-specific nutritional guidance in T2DM care.</div></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100299"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Removal notice to <\" DRESS Syndrome with the Use of Dapagliflozin: A Case Report and Review of Literature \">","authors":"Rebecca Badawi ,&nbsp;Layal Akl ,&nbsp;Karima Chafai ,&nbsp;Jean-Louis Nguewa ,&nbsp;Jean-François Gautier","doi":"10.1016/j.deman.2026.100307","DOIUrl":"10.1016/j.deman.2026.100307","url":null,"abstract":"","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"21 ","pages":"Article 100307"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147538068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}